Ring Therapeutics says it has demonstrated the ability to encapsidate nucleic acid payloads through in vitro assembly.

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.

STONY BROOK, NY / ACCESS Newswire / May 14, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), ...

Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform ...

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

Dyadic International, Inc. ("Dyadic”, "we”, "us”, "our”, or the "Company”) (NASDAQ: DYAI), a biotechnology company specializing in the development of functional recombinant solutions and proprietary ...

Scientists at Northwestern University have developed a new approach that directly combats the progression of ...